Report of the American Heart Association (AHA) scientific sessions 2013, Dallas

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 51-56

  Ishimori, Naoki ^a   Kinugawa, Shintaro ^a   Yamada, Satoshi ^a   Yokoshiki, Hisashi ^a   Mitsuyama, Hirofumi ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

American Heart Association; Japanese circulation society; Late breaking clinical trials; Scientific Sessions

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CYTOCHROME P450 2C9; DIURETIC AGENT; DOPAMINE; EDOXABAN; NESIRITIDE; PLACEBO; SPIRONOLACTONE; VARESPLADIB; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ARTICLE; BRAIN HEMORRHAGE; CATHETER ABLATION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HUMAN; HYPERTENSION; ISCHEMIA; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY (TOPIC); NEPHROSCLEROSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TEMPERATURE; VENOUS THROMBOEMBOLISM;

AMERICAN HEART ASSOCIATION; CARDIOLOGY; CARDIOVASCULAR DISEASES; CONGRESSES AS TOPIC; HUMANS; UNITED STATES;

EID: 84891055633     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1466     Document Type: Article

References (14)

1. Ozaki Y. European Society of Cardiology (ESC) Congress Report from Munich 2012. Circ J 2012; 76: 2530-2535.
2. Yamada H. Report of the American College of Cardiology (ACC) Scientific Sessions 2013, San Francisco: Highlighting late-breaking trials. Circ J 2013; 77: 1139-1145.
3. Fujita J. Report of the American Heart Association (AHA) Scientific Sessions 2012, Los Angeles. Circ J 2013; 77: 35-40.
4. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036.
5. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012; 366: 54-63.
6. Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med 2013 November 17, doi:10.1056/ NEJMoa1310519 [E-pub ahead of print].
7. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: The ROSE Acute Heart Failure Randomized Trial. JAMA 2013 November 18, doi:10.1001/ jama.2013.282190 [E-pub ahead of print].
8. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2013 November 18, doi:10.1056/NEJMoa1312808 [E-pub ahead of print].
9. Desai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, et al. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J 2011; 162: 966-972, e910.
10. Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, et al. Varespladib and cardiovascular events in patients with an acute coronary syndrome: The VISTA-16 randomized clinical trial. JAMA 2013 November 18, doi:10.1001/jama.2013.282836 [Epub ahead of print].
11. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renalartery stenosis. N Engl J Med 2013 November 18, doi:10.1056/ NEJMoa1310753 [E-pub ahead of print].
12. Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, et al. A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 2013 November 19, doi:10.1056/ NEJMoa1311386 [E-pub ahead of print].
13. Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, et al. A Pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 2013 November 19, doi:10.1056/NEJMoa1310669 [E-pub ahead of print].
14. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-2104.